Aurora Cannabis Inc (ACB)

NYSEHealthcare

$4.24
+$0.1 (+2.4%)
Last close

January 21, 2026 at 21:00 UTC

Interactive Chart
ACB
1H
3H
6H
12H
1D
1W
1M
3M
6M
12M (YTD)
2Y
5Y
All
About Aurora Cannabis Inc

Name

Aurora Cannabis Inc

CEO

Miguel Martin

Industry

Healthcare

Year Founded

2006

Employees

1,073

Aurora Cannabis Inc is a cannabis company that cultivates, processes, and distributes regulated products for adult-use and medical channels under strict quality systems. The business is built around controlled growing environments, standardized post-harvest methods, and documentation that satisfies varying provincial and international rules. Pharmacies, wholesalers, and licensed retailers rely on consistent specifications and clear labeling, while physicians and patients expect predictable formats and guidance that fits routine care. Aurora concentrates on scale that can be audited, rather than one-off launches, so supply and compliance move in step. Export pathways are developed in line with local authorities, reflecting a view that market access and stewardship go together. Within the consumer staples and healthcare ecosystem, the company presents cannabis as a category managed with the same patience and record-keeping that regulated products demand.

Analyst Ratings
Consensus Recommendation
Analyst consensus: 0 Buy, 7 Hold, 14 Sell
Buy0
Hold7
Sell14
Fundamentals & Financials
Revenue (TTM)
$355.1M
Net Income (TTM)
$70.4M
EPS (TTM)
$-1.2
ROA (TTM)
8.37%
Current Ratio
2.97
Dividend Yield
-

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement (Quarterly)
ItemQ3 2025
Revenue$88,198K
Cost of Sales$9,203K
Gross Profit$78,995K
Operating Income$36,856K
Net Income$31,669K
EPS$-0.97
Technical Indicators

Aurora Cannabis Inc's Technical Indicators Summary

ACB is currently exhibiting a bearish outlook with its price trading below key moving averages across short, medium, and long-term periods, indicating sustained downward pressure. Momentum indicators like the MACD and RSI reflect weakening buying interest, while the low ADX suggests the trend lacks strong conviction despite the overall negative sentiment. Additionally, the average true range points to moderate volatility, and declining on-balance volume supports the bearish case with reduced buying volume. With the stock price comfortably situated within the Bollinger Bands but failing to challenge resistance levels, the technical picture remains tilted toward cautious selling. Overall, ACB shows persistent bearishness amid subdued trend strength and weakening momentum.

Buy
0 signals
Neutral
7 signals
Sell
14 signals
Overall: Bearish67% Bearish signals
IndicatorValue
RSI (14)
40.32
Stochastic %K (14, 3, 3)
25.50
CCI (20)
-57.46
WPR (14)
-75.56
Momentum (10)
-0.11
MFI
33.80
MACD Level (12, 26)
-0.13
Bollinger Bands
$3.81 - $5.02
ATR (14)
$0.22 (5.18%)
ADX (14)
9.85
OBV
90,600,900
Simple Moving Averages
$4.25 - $4.88(5 indicators)
Exponential Moving Averages
$4.28 - $4.75(5 indicators)
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

ACB began the session with a modest -0.483% gap down, opening at 4.12 from yesterday’s 4.14. Early trade sees the peer group inching higher (1.15%), gently supporting ACB. ACB's slight decline amid peer group gains suggests limited stock-specific news or cautious investor sentiment.

Price Change

from $4.14 close

+$0.06

Trading Volume

Below avg (1.1M)

150K

vs S&P 500 Today

Underperforming Market

-0.80%

52-Week Position

Lower range

22.3%

Updated: January 21, 2026 at 15:32 UTC

Quote Summary
OpenPrevious Close
$4.12$4.14
Day Range52 Week Range
$4.12 - $4.28$3.42 - $6.91
VolumeAvg. Volume
1M1.6M
Market CapP/E Ratio
$238.2M-38.5